A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples ME Ackerman, B Moldt, RT Wyatt, AS Dugast, E McAndrew, S Tsoukas, ... Journal of immunological methods 366 (1-2), 8-19, 2011 | 456 | 2011 |
Computational strategies for dissecting the high-dimensional complexity of adaptive immune repertoires E Miho, A Yermanos, CR Weber, CT Berger, ST Reddy, V Greiff Frontiers in Immunology 9, 224, 2018 | 190 | 2018 |
Definition of the viral targets of protective HIV-1-specific T cell responses B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ... Journal of translational medicine 9 (1), 208, 2011 | 188 | 2011 |
High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control CT Berger, N Frahm, DA Price, B Mothe, M Ghebremichael, KL Hartman, ... Journal of virology 85 (18), 9334-9345, 2011 | 163 | 2011 |
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control B Mothe, A Llano, J Ibarrondo, J Zamarreño, M Schiaulini, C Miranda, ... PloS one 7 (1), e29717, 2012 | 158 | 2012 |
Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy P Blyszczuk, G Kania, T Dieterle, RR Marty, A Valaperti, C Berthonneche, ... Circulation research 105 (9), 912-920, 2009 | 139 | 2009 |
Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors DC Kroy, D Ciuffreda, JH Cooperrider, M Tomlinson, GD Hauck, J Aneja, ... Gastroenterology 146 (2), 550-561, 2014 | 115 | 2014 |
Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells YJ Yamanaka, CT Berger, M Sips, PC Cheney, G Alter, JC Love Integrative Biology 4 (10), 1175-1184, 2012 | 111 | 2012 |
High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition CT Berger, M Wolbers, P Meyer, T Daikeler, C Hess Rheumatology 48 (3), 258-261, 2009 | 105 | 2009 |
Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals AS Dugast, A Tonelli, CT Berger, ME Ackerman, G Sciaranghella, Q Liu, ... Virology 415 (2), 160-167, 2011 | 99 | 2011 |
The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. M Aschwanden, S Imfeld, D Staub, T Baldi, UA Walker, CT Berger, C Hess, ... Clinical and experimental rheumatology 33 (2 Suppl 89), S-113-5, 2015 | 98 | 2015 |
A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis FD Carmona, A Vaglio, SL Mackie, J Hernández-Rodríguez, PA Monach, ... The American Journal of Human Genetics 100 (1), 64-74, 2017 | 97 | 2017 |
A patient’s wish: anakinra in pregnancy CT Berger, M Recher, U Steiner, TM Hauser Annals of the rheumatic diseases 68 (11), 1794-1795, 2009 | 91 | 2009 |
Altered distribution of mucosal NK cells during HIV infection M Sips, G Sciaranghella, T Diefenbach, AS Dugast, CT Berger, Q Liu, ... Mucosal immunology 5 (1), 30, 2012 | 78 | 2012 |
Viral adaptation to immune selection pressure by HLA class I–restricted CTL responses targeting epitopes in HIV frameshift sequences CT Berger, JM Carlson, CJ Brumme, KL Hartman, ZL Brumme, LM Henry, ... Journal of Experimental Medicine 207 (1), 61-75, 2010 | 70 | 2010 |
Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy A Bischof, T Manigold, C Barro, I Heijnen, CT Berger, T Derfuss, J Kuhle, ... Annals of the rheumatic diseases, annrheumdis-2017-212045, 2017 | 67 | 2017 |
Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study M Aschwanden, E Schegk, S Imfeld, D Staub, C Rottenburger, CT Berger, ... Rheumatology, 2018 | 56 | 2018 |
Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations TM Nordmann, FD Juengling, M Recher, CT Berger, D Kalbermatten, ... Blood 129 (7), 879-882, 2017 | 53 | 2017 |
The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis CT Berger, G Sommer, M Aschwanden, D Staub, C Rottenburger, ... Swiss medical weekly 148 (3334), 2018 | 49 | 2018 |
Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers NS Fink, C Urech, CT Berger, I Hoesli, W Holzgreve, J Bitzer, J Alder The Journal of Maternal-Fetal & Neonatal Medicine 23 (6), 488-500, 2010 | 46 | 2010 |